Among patients with aggressive tRCC, Pt1-2 and Pt1-3 harbored the ASPL-TFE3 gene fusion and RBM10-TFE3 gene fusion, respectively. Here, TFE3 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.